Compare AUPH & RVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUPH | RVT |
|---|---|---|
| Founded | 1993 | 1986 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 2014 | N/A |
| Metric | AUPH | RVT |
|---|---|---|
| Price | $15.34 | $18.13 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $17.25 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 382.7K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.32% |
| EPS Growth | ★ 5075.00 | N/A |
| EPS | 0.25 | ★ 2.95 |
| Revenue | ★ $283,055,000.00 | N/A |
| Revenue This Year | $17.54 | N/A |
| Revenue Next Year | $15.74 | N/A |
| P/E Ratio | $62.56 | ★ $6.16 |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $8.80 | $14.78 |
| 52 Week High | $19.25 | $18.88 |
| Indicator | AUPH | RVT |
|---|---|---|
| Relative Strength Index (RSI) | 42.25 | 51.03 |
| Support Level | $14.68 | $18.06 |
| Resistance Level | $16.38 | $18.69 |
| Average True Range (ATR) | 0.63 | 0.26 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 11.69 | 46.67 |
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
Royce Small-Cap Trust Inc is a diversified closed-end investment company that invests in equity securities of small-cap companies. The company portfolio includes sectors such as Industrials, Financials, Information Technology, Health Care, and Consumer Discretionary.